New COVID Drug Developed By DRDO Receives Emergency Authorization

India’s regulator has approved a new, oral COVID-19 drug that promises to reduce hospitalisation time and oxygen dependency for moderate to severe cases, reports the Economic Times.

The first 10,000 doses are expected to be available by next week.

Effective COVID-19 vaccine

The 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation has proved to be effective in three phases of trials on COVID-19 patients and can be easily mass produced, officials said, adding...

https://mfame.guru/new-covid-drug-developed-by-drdo-receives-emergency-authorization/

Politicians, CEOs spar over supply chain impact of sharing intellectual property

(Credit: Nataliya Vaitkevich)

This is an excerpt from the May 6, 2021 edition of Medically Necessary, a health care supply chain newsletterSubscribe here.

The decision: On Wednesday, U.S. Trade Representative Katherine Tai announced that the Biden administration supports waiving intellectual property rights for COVID-19 vaccines. 

“This is a global health crisis, and the extraordinary circumstances of the COVID-19 pandemic call for extraordinary measures,” Tai said, according to a statement.

U.S. support doesn’t...

https://s29755.pcdn.co/news/politicians-ceos-spar-over-supply-chain-impact-of-sharing-intellectual-property

168 Major Blood Clots Following The Dose of Covid-19 Vaccine

  • Britain’s medicines regulator on Thursday said there had been 168 major blood clots following a dose of AstraZeneca’s Covid-19 vaccine.
  • It is a rate of 7.9 clots per million doses, a jump in incidence from the previous week’s figure.
  • This was up from the 100 cases reported last week, when the overall case incidence was 4.9 per million doses.
  • There has been scrutiny of the AstraZeneca vaccine on the issue of the very rare clots and some countries, including Britain, have recommended that only...

https://mfame.guru/168-major-blood-clots-following-the-dose-of-covid-19-vaccine/

An-124 super freighter delivers machinery for U.S. vaccine fill plant

The open rear tail of a giant Russian cargo plane unloading a big crate.

A massive piece of machinery that can produce up to 30 million doses of COVID vaccine per month, and help alleviate production bottlenecks, landed Saturday at Chicago Rockford International Airport on a specialized cargo jet.

The flight was operated by Russian all-cargo carrier Volga-Dnepr Airlines, Zachary Oakley, deputy director of operations and planning at the Greater Rockford Airport Authority, confirmed. 

The vaccine filling machine and isolator were delivered to a plant being built by...

https://www.freightwaves.com/news/an-124-super-freighter-delivers-machinery-for-us-vaccine-fill-plant

Nearly 85% Fewer J&J Vaccine Doses to States

The U.S. government will allocate nearly 85% fewer Johnson & Johnson COVID-19 vaccine doses to states next week, according to data from the Centers for Disease Control and Prevention (CDC), due to uneven production related in part to problems at a Baltimore manufacturing plant, reports reuters.

Department of Health and Human Services

Allocations will fall to 785,500 doses from 4.95 million doses this week. The data does not include a federal retail pharmacy program.

An official from the U.S....

https://mfame.guru/nearly-85-fewer-jj-vaccine-doses-to-states/

Positive publicity from COVID can lift air cargo, trade group says

The air cargo industry rallied around the common mission of delivering vital medical supplies to defeat the COVID-19 virus. A multi-sector trade association wants to capitalize on that unity of purpose to drive collaboration on issues important to the sector’s long-term growth and society, such as digitization and sustainability.

“Prior to COVID, we were mostly focused on moving the boxes, but we often overlooked the value to society. COVID changed that. It was the best public relations campaign...

https://s29755.pcdn.co/news/positive-publicity-from-covid-can-lift-air-cargo-trade-group-says

Mass production of COVID vaccines — Medically Necessary

Medically Necessary is a FreightWaves podcast about the health care supply chain — how we get drugs, devices and medical supplies to medical providers and patients.

FreightWaves’ Matt Blois talks to executives steering their companies through the pandemic and researchers with ideas to make health care supply chains more efficient.

In this first episode, Blois explores the rapid changes medical supply chains underwent to keep up with the COVID-19 vaccine production demand. Blois speaks with Robert...

https://www.freightwaves.com/news/mass-production-of-covid-vaccines-medically-necessary

WHO Says No To Use Ivermectin in Patients with Covid-19

  • The WHO said Wednesday that ivermectin — touted by some on social media as a Covid-19 ‘miracle cure’ — should not be used to treat coronavirus patients.
  • The WHO issued guidelines saying ivermectin should only be used on Covid-19 patients in clinical trial settings.
  • The UN health agency said there was a ‘very low certainty of evidence’ on ivermectin’s effects on mortality, hospital admission and getting rid of the virus from the body.

A recent news article published in the First Post reveals...

https://mfame.guru/who-says-no-to-use-ivermectin-in-patients-with-covid-19/

Medically Necessary: The enormous challenge of scaling up global vaccine production

This is an excerpt from the March 30, 2021 edition of Medically Necessary, a health care supply chain newsletterSubscribe here.

The big challenge: Estimates vary widely, but the world will likely need billions — maybe more than 10 billion — doses of COVID-19 vaccines to stop the spread of the new coronavirus.

  • Drugmakers are aiming to produce 14 billion doses of COVID-19 vaccines this year, according to a tally of disclosures by vaccine manufacturers.

That’s much more vaccine than the world...

https://s29755.pcdn.co/news/medically-necessary-the-enormous-challenge-of-scaling-up-global-vaccine-production

Medically Necessary: Rideshare companies angle for a bigger piece of the health care supply chain

This is an excerpt from the March 25, 2021 edition of Medically Necessary, a health care supply chain newsletterSubscribe here.

Good afternoon. Medically Necessary is a newsletter by Matt Blois about the health care supply chain — how we get drugs, devices and medical supplies to health care providers and patients.

Rideshare companies angle for a bigger piece of the health care supply chain

A driver for the non-emergency medical transportation company Veyo helps a patient get to a doctor’s...

https://www.freightwaves.com/news/medically-necessary-rideshare-companies-angle-for-a-bigger-piece-of-the-health-care-supply-chain

Join Our Newsletter
Enter your email to receive a weekly round-up of shipping news.